Agilent Technologies Shares Outstanding 2006-2018 | A

Current and historical number of shares outstanding for Agilent Technologies (A) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Agilent Technologies Annual Shares Outstanding
(Millions of US $)
2017 $326
2016 $329
2015 $335
2014 $338
2013 $345
2012 $353
2011 $355
2010 $353
2009 $346
2008 $371
2007 $406
2006 $441
2005 $500
Agilent Technologies Quarterly Shares Outstanding
(Millions of US $)
Q3 2018 $324
Q2 2018 $326
Q1 2018 $323
Q4 2017 $326
Q3 2017 $326
Q2 2017 $325
Q1 2017 $326
Q4 2016 $329
Q3 2016 $328
Q2 2016 $328
Q1 2016 $332
Q4 2015 $335
Q3 2015 $334
Q2 2015 $337
Q1 2015 $338
Q4 2014 $338
Q3 2014 $338
Q2 2014 $337
Q1 2014 $338
Q4 2013 $336
Q3 2013 $343
Q2 2013 $349
Q1 2013 $352
Q4 2012 $353
Q3 2012 $353
Q2 2012 $354
Q1 2012 $352
Q4 2011 $355
Q3 2011 $357
Q2 2011 $355
Q1 2011 $355
Q4 2010 $353
Q3 2010 $352
Q2 2010 $354
Q1 2010 $354
Q4 2009 $346
Q3 2009 $345
Q2 2009 $344
Q1 2009 $352
Q4 2008 $371
Q3 2008 $372
Q2 2008 $370
Q1 2008 $382
Q4 2007 $406
Q3 2007 $407
Q2 2007 $413
Q1 2007 $418
Q4 2006 $441
Q3 2006 $422
Q2 2006 $442
Q1 2006 $483
Q4 2005 $500
Q3 2005 $499
Q2 2005 $496
Q1 2005 $496
Sector Industry Market Cap Revenue
Computer and Technology Electrical Test Equipment $20.688B $4.472B
Agilent Technologies Inc. focuses its expertise on six key markets: Food; Environmental and Forensics; Pharmaceutical; Diagnostics; Chemical and Energy; and Research. Agilent helps ensure that their global food supply is free of contaminants, whether chemical, viral, bacterial or microbiological. The Company's customers include government regulators and labs that control food safety, as well as private companies that produce, package and sell food to the public. Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry. Its solutions provide precise answers for every segment of the pharmaceutical industry, from disease research and drug discovery to drug development, manufacturing and quality control. Agilent gives doctors a head start in the fight against cancer and other diseases. Agilent's immunohistochemistry (IHC) products provide high staining quality, improved standardization and increased efficiency enabling the ultimate goal of increased patient safety.
Stock Name Country Market Cap PE Ratio
Fortive (FTV) United States $28.019B 24.47
AMETEK (AME) United States $17.696B 25.69
Cognex (CGNX) United States $9.020B 37.45
Teradyne (TER) United States $7.320B 19.25
National Instruments (NATI) United States $5.931B 40.78
Itron (ITRI) United States $2.454B 25.81